REVLIMID

This brand name is authorized in United States. It is also authorized in Australia, Austria, Brazil, Canada, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Japan, Lithuania, Mexico, Netherlands, New Zealand, Poland, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug REVLIMID contains one active pharmaceutical ingredient (API):

1	Lenalidomide UNII F0P408N6V4 - LENALIDOMIDE
	Lenalidomide binds directly to cereblon, a component of a cullin ring E3 ubiquitin ligase enzyme complex that includes deoxyribonucleic acid (DNA) damage-binding protein 1(DDB1), cullin 4 (CUL4), and regulator of cullins 1 (Roc1). Specifically, lenalidomide inhibits proliferation and enhances apoptosis of certain haematopoietic tumour cells (including MM plasma tumour cells, follicular lymphoma tumour cells and those with deletions of chromosome 5), enhances T cell- and Natural Killer (NK) cell-mediated immunity and increases the number of NK, T and NK T cells. The lenalidomide mechanism of action also includes additional activities such as anti-angiogenic and proerythropoietic properties.
	Read more about Lenalidomide

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
REVLIMID Hard capsule	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
L04AX04	Lenalidomide	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AX Other immunosuppressants
Discover more medicines within L04AX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	11029L, 11036W, 11041D, 11042E, 11055W, 11062F, 11063G, 11064H, 11964Q, 11965R, 11966T, 11967W, 11968X, 11969Y, 12004T, 12011E, 12012F, 12018M, 12019N, 12020P, 12026Y, 12034J, 12035K, 12036L, 12037M, 12038N, 12039P, 12050F, 12057N, 12058P, 12059Q, 12060R, 12061T, 12062W, 12068E, 12069F, 12070G, 12071H, 2796E, 2798G, 2799H, 2802L, 5783J, 5784K, 5785L, 5786M, 9642L, 9643M, 9644N, 9645P
BR	Câmara de Regulação do Mercado de Medicamentos	562418040000102, 562418040000202, 562418040000302, 562418040000402, 562419060000701, 562419060000801, 562420020001007, 562420020001107, 562420020001207, 562420020001307, 562420020001407
CA	Health Products and Food Branch	02304899, 02304902, 02317699, 02317710, 02440601, 02459418
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	29022-09-09, 29024-09-09, 29025-09-09, 29026-09-09, 3161-MEE-0218
EE	Ravimiamet	1299540, 1299551, 1299562, 1299573, 1594199, 1594201, 1618938, 1618949, 1677764, 1739796, 1739864, 1796261, 1796272, 1796283
ES	Centro de información online de medicamentos de la AEMPS	07391001, 07391002, 07391003, 07391004, 107391009
FI	Lääkealan turvallisuus- ja kehittämiskeskus	096524, 096533, 096542, 096551, 471032, 524729
FR	Base de données publique des médicaments	60245253, 63841924, 65512525, 65786896, 67232333, 68425602, 69470867
GB	Medicines & Healthcare Products Regulatory Agency	117555, 117558, 117561, 117566, 233076, 298952, 298955
HK	Department of Health Drug Office	59190, 59191, 59192, 59193, 62180, 62181, 62182, 62183
IE	Health Products Regulatory Authority	88008, 88717, 88729, 88781, 88932
IL	מִשְׂרַד הַבְּרִיאוּת	6275, 6276, 6277, 6278
JP	医薬品医療機器総合機構	4291024M1024, 4291024M2020
LT	Valstybinė vaistų kontrolės tarnyba	1030700, 1030701, 1030702, 1030703, 1067916, 1067917, 1072173, 1072174, 1076825, 1083709, 1083710, 1088013, 1088014
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	101M2010
NL	Z-Index G-Standaard, PRK	113387, 125733, 125741, 83909, 83917, 83925, 83933
NZ	Medicines and Medical Devices Safety Authority	13398, 13399, 13400, 13401, 18134, 18135, 18136
PL	Rejestru Produktów Leczniczych	100069827, 100147220, 100148082, 100153019, 100315887, 100315901, 100382553
SG	Health Sciences Authority	13662P, 13663P, 13664P, 13665P
TN	Direction de la Pharmacie et du Médicament	13483021H, 13483022H, 13483023H, 13483024H
TR	İlaç ve Tıbbi Cihaz Kurumu	8699538154822, 8699538154839, 8699538154846, 8699538154853
US	FDA, National Drug Code	59572-402, 59572-405, 59572-410, 59572-415, 59572-420, 59572-425
ZA	Health Products Regulatory Authority	47/32/0507, 47/32/0508, 47/32/0509, 47/32/0510